Huiqin Luo

577 total citations
28 papers, 434 citations indexed

About

Huiqin Luo is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Huiqin Luo has authored 28 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 7 papers in Surgery and 7 papers in Molecular Biology. Recurrent topics in Huiqin Luo's work include Gastric Cancer Management and Outcomes (6 papers), Inflammatory mediators and NSAID effects (4 papers) and Mitochondrial Function and Pathology (3 papers). Huiqin Luo is often cited by papers focused on Gastric Cancer Management and Outcomes (6 papers), Inflammatory mediators and NSAID effects (4 papers) and Mitochondrial Function and Pathology (3 papers). Huiqin Luo collaborates with scholars based in China, United States and Czechia. Huiqin Luo's co-authors include Linlin Sun, Guoliang Meng, Mengting Xu, Jin Yu, Jingyao Zhang, Yun Chen, Lulu Liu, Qi‐Gang Zhou, Shengju Yang and Yun Chen and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and Annals of Oncology.

In The Last Decade

Huiqin Luo

25 papers receiving 433 citations

Peers

Huiqin Luo
Li Yan China
Yongping Guo China
Tao-Hua Lan China
Zhimin Mao China
Xinglei Zhu China
Jiarong Gao China
Fengxia Lin China
Danli Yang China
Lili Lin China
Li Yan China
Huiqin Luo
Citations per year, relative to Huiqin Luo Huiqin Luo (= 1×) peers Li Yan

Countries citing papers authored by Huiqin Luo

Since Specialization
Citations

This map shows the geographic impact of Huiqin Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huiqin Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huiqin Luo more than expected).

Fields of papers citing papers by Huiqin Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huiqin Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huiqin Luo. The network helps show where Huiqin Luo may publish in the future.

Co-authorship network of co-authors of Huiqin Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Huiqin Luo. A scholar is included among the top collaborators of Huiqin Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huiqin Luo. Huiqin Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Zhang, Guoying, Wenjing Jia, Liying Liu, et al.. (2024). Caffeoylquinic acids from Silphium perfoliatum L. show hepatoprotective effects on cholestatic mice by regulating enterohepatic circulation of bile acids. Journal of Ethnopharmacology. 337(Pt 2). 118870–118870. 3 indexed citations
4.
Xu, Huijun, Yang Yang, Mengge Li, et al.. (2024). Safety and Efficacy of Rechallenge With Immune Checkpoint Inhibitors in Advanced Solid Tumor: A Systematic Review and Meta‐Analysis. Cancer Medicine. 13(20). e70324–e70324. 5 indexed citations
5.
6.
7.
Li, Mengge, Huiqin Luo, Ying Yan, et al.. (2022). Serological and Molecular Characterization of Hepatitis B Virus Infection in Gastric Cancer. Frontiers in Cellular and Infection Microbiology. 12. 894836–894836. 7 indexed citations
8.
9.
He, Yifu, Ying Yan, Huiqin Luo, et al.. (2021). Efficacy and safety of intermittent versus continuous dosing schedule of apatinib combined with docetaxel as second-line treatment for advanced gastric cancer.. Journal of Clinical Oncology. 39(15_suppl). e16018–e16018. 1 indexed citations
10.
Chen, Jian, et al.. (2020). Limb‑bud and heart as a novel biomarker for gastric intestinal type adenocarcinoma. Oncology Letters. 20(3). 2209–2216. 2 indexed citations
11.
12.
13.
Sun, Linlin, Yun Chen, Huiqin Luo, et al.. (2019). Ca2+/calmodulin-dependent protein kinase II regulation by inhibitor 1 of protein phosphatase 1 alleviates necroptosis in high glucose-induced cardiomyocytes injury. Biochemical Pharmacology. 163. 194–205. 27 indexed citations
14.
He, Yifu, Ying Yan, Tingjuan Xu, et al.. (2019). Efficacy and safety of intermittent dosing schedule of apatinib for advanced gastric cancer in second-line setting. Annals of Oncology. 30. iv22–iv22. 2 indexed citations
15.
Luo, Huiqin, et al.. (2018). Effects of Human Interleukin-10 on Ventilator-Associated Lung Injury in Rats. Inflammation. 42(2). 538–547. 9 indexed citations
16.
Zhang, Jingyao, Jin Yu, Yun Chen, et al.. (2018). Exogenous Hydrogen Sulfide Supplement Attenuates Isoproterenol‐Induced Myocardial Hypertrophy in a Sirtuin 3‐Dependent Manner. Oxidative Medicine and Cellular Longevity. 2018(1). 9396089–9396089. 37 indexed citations
17.
Zhang, Jingyao, Yun Chen, Huiqin Luo, et al.. (2018). Recent Update on the Pharmacological Effects and Mechanisms of Dihydromyricetin. Frontiers in Pharmacology. 9. 146 indexed citations
18.
Liu, Lulu, Jin Yu, Jingyao Zhang, et al.. (2017). Dihydromyricetin attenuated Ang II induced cardiac fibroblasts proliferation related to inhibitory of oxidative stress. European Journal of Pharmacology. 807. 159–167. 48 indexed citations
19.
Luo, Huiqin, et al.. (2014). Sodium Hydrosulfide Relieves Neuropathic Pain in Chronic Constriction Injured Rats. Evidence-based Complementary and Alternative Medicine. 2014(1). 514898–514898. 16 indexed citations
20.
Luo, Huiqin, et al.. (2013). Research progress of gaseous signal molecule hydrogen sulfide. 34(8). 764–768. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Li Yan Breakdown of academic impact, for papers by Yongping Guo Breakdown of academic impact, for papers by Tao-Hua Lan Breakdown of academic impact, for papers by Zhimin Mao Breakdown of academic impact, for papers by Xinglei Zhu Breakdown of academic impact, for papers by Jiarong Gao Breakdown of academic impact, for papers by Fengxia Lin Breakdown of academic impact, for papers by Danli Yang Breakdown of academic impact, for papers by Lili Lin
Rankless by CCL
2026